Robert Kramer
Chief Tech/Sci/R&D Officer presso PORTAGE BIOTECH INC.
Patrimonio netto: 82 766 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Robert Kramer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 14 | |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Phusis Therapeutics, Inc. is a private company that specializes in molecule therapeutics for cancer therapy. The company is based in Houston, TX and was founded by D. Lynn Kirkpatrick. The company focuses on developing inhibitors for PLEKHA7, RAL, Tiam1, and CERK, which are all important in cancer treatment.
2
| Private Company | Biotechnology | 2 |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.
2
| Private Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert Kramer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| IM CANNABIS CORP. | Pharmaceuticals: Other | Chief Executive Officer | |
| THREED CAPITAL INC. | Investment Managers | Director/Board Member | |
Waymar Resources Ltd.
 Waymar Resources Ltd. Other Metals/MineralsNon-Energy Minerals Waymar Resources Ltd. engages in the acquisition, exploration, and development of mineral properties in Colombia. It currently operates Anzá project located in Colombia. The company was founded on October 26, 1994 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | Chief Executive Officer | |
| PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree | |
Viscogliosi Brothers LLC
 Viscogliosi Brothers LLC Investment ManagersFinance Viscogliosi Brothers LLC is a venture capital, private equity and merchant banking firm which was founded in 1999 by Marc Viscogliosi, John Viscogliosi and Anthony Viscogliosi. The firm headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NAVIOS MARITIME HOLDINGS INC. | Marine Shipping | Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MANX FINANCIAL GROUP PLC | Regional Banks | Chairman Director/Board Member | |
| St. Germain Capital Corp. | President | ||
Serina Therapeutics, Inc.
 Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Miscellaneous Commercial Services | Director/Board Member | |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The private company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the private company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Founder Founder | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Miscellaneous Commercial Services | Director of Finance/CFO Chairman | |
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Director/Board Member Founder Corporate Officer/Principal | |
| SALVARX GROUP PLC | Biotechnology | Chairman Director of Finance/CFO Founder Founder | |
| Boston Bioconsulting LLC | Founder | ||
Chelsea Avondale Ltd.
 Chelsea Avondale Ltd. Property/Casualty InsuranceFinance Chelsea Avondale Ltd. has developed Skynet, a precision risk technology for property and casualty insurance. The company is based in Hamilton, Bermuda and has subsidiaries in Barbados. Skynet was created by going back to the scientific principles that cause insurance claims. The first implementation of Skynet was completed in Chelsea Avondale's wholly owned Bermudian insurance company, Max Insurance. Chelsea Avondale believes that scientific underwriting is the future of insurance. The company was founded by Gregory H. Bailey and the CEO is Nilesh Mukundrai G. Vasani. | Property/Casualty Insurance | Director/Board Member Founder | |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder Founder Founder | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| POOL SAFE INC. | Miscellaneous | Director/Board Member | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 19 |
| Regno Unito | 10 |
| Canada | 9 |
| Irlanda | 3 |
| Giappone | 3 |
Settori
| Health Technology | 25 |
| Finance | 9 |
| Commercial Services | 5 |
| Non-Energy Minerals | 4 |
| Consumer Services | 4 |
Posizioni
| Director/Board Member | 149 |
| Corporate Officer/Principal | 64 |
| Independent Dir/Board Member | 41 |
| Chairman | 34 |
| Founder | 31 |
Contatti più connessi
| Insiders | |
|---|---|
| Jim Mellon | 51 |
| Gregory Bailey | 36 |
| Declan Doogan | 28 |
| Steven Mintz | 25 |
| Allan Shaw | 23 |
| Stephen Allen Hurly | 16 |
| Robert Glassman | 16 |
| Ian Walters | 15 |
| Mark Simon | 13 |
| David Chaplin | 12 |
| Kamlesh Shah | 10 |
| Brian Wiley | 9 |
| Jonathan Charles Alexander Skipper | 9 |
| Joseph Ciavarella | 9 |
| Linda Kozick | 7 |
- Borsa valori
- Insiders
- Robert Kramer
- Connessioni Società
